Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引:0
作者
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:687 / 697
页数:10
相关论文
共 50 条
  • [21] Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
    Park, S.
    Koo, J. S.
    Kim, M. S.
    Park, H. S.
    Lee, J. S.
    Lee, J. S.
    Kim, S. I.
    Park, B. -W.
    Lee, K. S.
    ANNALS OF ONCOLOGY, 2011, 22 (08) : 1755 - 1762
  • [22] Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
    Basaran, Gul A.
    Twelves, Chris
    Dieras, Veronique
    Cortes, Javier
    Awada, Ahmad
    CANCER TREATMENT REVIEWS, 2018, 63 : 144 - 155
  • [23] Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer
    Chen, Xiao-song
    Ma, Chuan-dong
    Wu, Jia-yi
    Yang, Wen-tao
    Lu, Hong-fen
    Wu, Jiong
    Lu, Jin-song
    Shao, Zhi-min
    Shen, Zhen-zhou
    Shen, Kun-wei
    TUMORI JOURNAL, 2010, 96 (01): : 103 - 110
  • [24] High snail expression predicts a poor prognosis in breast invasive ductal carcinoma patients with HER2/EGFR-positive subtypes
    Chang, Hui-Yu
    Tseng, Yu-Kai
    Chen, Yu-Chia
    Shu, Chih-Wen
    Lin, Miaw-I.
    Liou, Huei-Han
    Fu, Ting-Ying
    Lin, Yun-Chung
    Ger, Luo-Ping
    Yeh, Ming-Hsin
    Liu, Pei-Feng
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 314 - 320
  • [25] CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
    Kimbung, Siker
    Inasu, Maria
    Stalhammar, Tor
    Nodin, Bjorn
    Elebro, Karin
    Tryggvadottir, Helga
    Ygland Rodstrom, Maria
    Jirstrom, Karin
    Isaksson, Karolin
    Jernstrom, Helena
    Borgquist, Signe
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [26] Stromal Tumor-Infiltrating Lymphocytes in Hormone Receptor-Positive/HER2 Negative Metastatic Breast Cancer
    Pabba, Anirudh
    Zels, Gitte
    De Schepper, Maxim
    Geukens, Tatjana
    Van Baelen, Karen
    Maetens, Marion
    Leduc, Sophia
    Nguyen, Ha-Linh
    Mahdami, Amena
    Van Cauwenberge, Josephine
    Borremans, Kristien
    Izci, Hava
    Hatse, Sigrid
    Neven, Patrick
    Wildiers, Hans
    Biganzoli, Elia
    van den Bogaert, Wouter
    Richard, Francois
    Floris, Giuseppe
    Desmedt, Christine
    MODERN PATHOLOGY, 2025, 38 (02)
  • [27] CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
    Siker Kimbung
    Maria Inasu
    Tor Stålhammar
    Björn Nodin
    Karin Elebro
    Helga Tryggvadottir
    Maria Ygland Rödström
    Karin Jirström
    Karolin Isaksson
    Helena Jernström
    Signe Borgquist
    Breast Cancer Research, 22
  • [28] ESF1 and MIPEP proteins promote estrogen receptor-positive breast cancer proliferation and are associated with patient prognosis
    Yu, Qing
    Qu, Chunhua
    Liang, Jinliang
    Chen, Peiqi
    Zhang, Kaiying
    Zhang, Yanji
    Zhang, Yuening
    Li, Zherui
    Liu, Shaojun
    Yang, Zhaoshou
    Sun, Hongyan
    Yang, Anli
    CLINICAL PROTEOMICS, 2024, 21 (01)
  • [29] Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
    Kim, Hee Jeong
    Kwon, Hyunwook
    Lee, Jong Won
    Kim, Hwa Jung
    Lee, Sae Byul
    Park, Hee Sung
    Sohn, Guiyun
    Lee, Yura
    Koh, Beom Seok
    Yu, Jong Han
    Son, Byung Ho
    Ahn, Sei Hyun
    BREAST CANCER RESEARCH, 2015, 17
  • [30] Clinicopathologic features, genomic profiles and outcomes of younger vs. older Chinese hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer patients
    Wang, Jinhao
    Liu, Yaxin
    Liang, Yuehua
    Zhang, Yue
    Dong, Hang
    Zheng, Tiantian
    Yu, Jianjun
    Du, Pan
    Jia, Shidong
    King, Bonnie L. L.
    Wang, Jing
    Liu, Xiaoran
    Li, Huiping
    FRONTIERS IN ONCOLOGY, 2023, 13